Novavax' H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data
September 23, 2014 at 08:33 AM EDT
Vaccine and adjuvant were well-tolerated, consistent with the company's prior studies with saponin-based ...
